New research on chronic pain, toxic exposure and opioid use
The VA's Office of Research and Development has released three significant research studies examining chronic pain management, the connection between toxic exposure and suicide risk, and dental health complications from long-term opioid use. These findings offer important insights for veterans dealing with service-connected health conditions and highlight both promising treatment approaches and serious health risks that warrant attention from the veteran community.
The first study examined nearly 800 veterans across six VA health systems and found that the VA's Whole Health approach significantly reduced how much chronic pain interfered with veterans' daily lives. Whole Health is an individualized, interdisciplinary care model that focuses on personal health goals, non-drug therapies, and wellness coaching rather than relying primarily on medication. After 12 months of treatment, veterans receiving Whole Health care showed greater improvements in pain interference compared to those receiving standard care or cognitive behavioral therapy alone, and the study demonstrated this approach can be delivered effectively through telehealth.
The second study, conducted by VA Durham researchers using data from nearly 250,000 veterans in the Million Veteran Program, revealed a troubling link between toxic exposure and suicide risk. Veterans who experienced multiple toxic exposures had 17 percent higher odds of suicidal thoughts and behaviors compared to veterans who did not report exposures. The research assessed exposure to nine different toxins and found that each additional toxic exposure increased suicide risk across all service eras, from pre-Vietnam through post-9/11, with the connection largely attributed to higher rates of PTSD and depression among veterans with greater exposure histories.
The third study, led by VA Connecticut researchers, examined data from more than 2 million veterans and found that long-term opioid therapy significantly increased the risk of infection-related dental disease. Among the veterans studied, 36 percent received long-term opioid therapy, and those taking opioid medications for more than 90 days had a 24 percent higher chance of experiencing tooth decay, infections, or tooth loss. Researchers believe the immune suppression and reduced saliva flow caused by opioids explain this connection, suggesting that oral health risks need consideration when prescribing long-term opioid therapy.
These findings matter for disabled veterans navigating the VA healthcare system because they highlight both opportunities and risks in current treatment approaches. The Whole Health study offers hope for veterans struggling with chronic pain who may be seeking alternatives to medication-based treatment, while the opioid study underscores the importance of monitoring additional health complications for those on long-term pain management. The toxic exposure research reinforces the need for comprehensive mental health screening for veterans with exposure histories, particularly as the PACT Act expands recognition of toxic exposure conditions.
Veterans currently managing chronic pain should discuss Whole Health options with their VA providers, as this approach is now available at VA facilities and has demonstrated effectiveness through telehealth delivery. Those on long-term opioid therapy should prioritize regular dental care and discuss oral health monitoring with their healthcare team. Veterans with toxic exposure histories, especially those experiencing depression or PTSD symptoms, should ensure their providers are aware of their exposure history during mental health assessments, as this information is crucial for comprehensive suicide risk evaluation and appropriate care planning.